Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2009/091/000628
CTRI/2009/091/000628
Not yet recruiting
Phase 1

An open-label, randomized, 2-period, cross-over study to determine the relative bioavailability of AEB071 from a coated tablet versus a capsule in healthy subjects

ovartis Healthcare Private Limited0 sites16 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
ovartis Healthcare Private Limited
Enrollment
16
Status
Not yet recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
ovartis Healthcare Private Limited

Eligibility Criteria

Inclusion Criteria

  • •Health volunteers of either gender between 18 to 45 years.
  • •Women should be postmenopausal or surgically sterialized
  • •Males should be using contraception

Exclusion Criteria

  • •History of any major illness, and abnormal lab assessment
  • •Those who have intension to vaccine for 2 weeks or have had vaccine in the last 2 weeks

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A randomized, open-label, two-period, crossover study to determine the pharmacokinetics of reconstituted lyophilized Erelzi and Enbrel® (US-licensed) following a single subcutaneous injection in healthy male subjects.
NL-OMON45782Hexal AG56
Active, not recruiting
Phase 1
A study to compare how easily patients with breathing conditions (asthma, chronic obstructive pulmonary disease (COPD) and asthma COPD overlap syndrome) can use two different types of inhaler.
EUCTR2014-004564-38-DEMundipharma Research Limited368
Active, not recruiting
Phase 1
A study to compare how easily patients with breathing conditions (asthma, chronic obstructive pulmonary disease (COPD) and asthma COPD overlap syndrome) can use two different types of inhaler.
EUCTR2014-004564-38-GBMundipharma Research Limited369
Completed
Phase 1
A First In Human study to compare 2 formulations of dexmedetomidinePain ManagementAnaesthesiology - Pain management
ACTRN12615001168549Clinical Network Services Pty Ltd12
Completed
Not Applicable
A study in healthy subjects to explore the blood levels of a drug when released from the IntelliCap capsule as compared to a marketed drug capsulePharmaceutical research and developmentNot Applicable
ISRCTN45336965Medimetrics Personalized Drug Delivery B.V. (Netherlands)14